Amorette Barber

1.4k total citations
27 papers, 1.1k citations indexed

About

Amorette Barber is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Amorette Barber has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 18 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Amorette Barber's work include Immune Cell Function and Interaction (19 papers), CAR-T cell therapy research (18 papers) and T-cell and B-cell Immunology (13 papers). Amorette Barber is often cited by papers focused on Immune Cell Function and Interaction (19 papers), CAR-T cell therapy research (18 papers) and T-cell and B-cell Immunology (13 papers). Amorette Barber collaborates with scholars based in United States and Morocco. Amorette Barber's co-authors include Charles L. Sentman, Tong Zhang, Paul W. Spear, Agnieszka Rynda‐Apple, José R. Conejo-García, Katherine F. Roby, Leslie R. DeMars, Yolanda C. Nesbeth, Yvon G. Durant and Diana G. Martinez and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Amorette Barber

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amorette Barber United States 18 809 805 205 198 137 27 1.1k
Andrew D. Fesnak United States 9 886 1.1× 517 0.6× 396 1.9× 385 1.9× 219 1.6× 20 1.2k
Connie P.M. Duong United States 15 1.1k 1.4× 683 0.8× 379 1.8× 259 1.3× 313 2.3× 24 1.4k
Zachary A. Borman United States 11 1.0k 1.3× 998 1.2× 298 1.5× 164 0.8× 374 2.7× 18 1.4k
Alba Rodríguez-García United States 13 637 0.8× 385 0.5× 283 1.4× 181 0.9× 245 1.8× 17 876
Marc Wehrli United States 12 363 0.4× 399 0.5× 360 1.8× 109 0.6× 100 0.7× 24 830
Clay Lyddane United States 7 626 0.8× 455 0.6× 307 1.5× 139 0.7× 247 1.8× 7 909
Nicole Berndt Germany 17 461 0.6× 367 0.5× 275 1.3× 204 1.0× 89 0.6× 34 798
Angela C. Boroughs United States 8 641 0.8× 321 0.4× 264 1.3× 245 1.2× 203 1.5× 8 812
Jessica Hartmann Germany 16 864 1.1× 483 0.6× 471 2.3× 168 0.8× 379 2.8× 25 1.2k

Countries citing papers authored by Amorette Barber

Since Specialization
Citations

This map shows the geographic impact of Amorette Barber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amorette Barber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amorette Barber more than expected).

Fields of papers citing papers by Amorette Barber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amorette Barber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amorette Barber. The network helps show where Amorette Barber may publish in the future.

Co-authorship network of co-authors of Amorette Barber

This figure shows the co-authorship network connecting the top 25 collaborators of Amorette Barber. A scholar is included among the top collaborators of Amorette Barber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amorette Barber. Amorette Barber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barber, Amorette, Xiaohong Wang, Anupama Gopisetty, Leonardo Mirandola, & Maurizio Chiriva‐Internati. (2021). Abstract LB148: Gamma delta T cells engineered with a chimeric PD-1 receptor effectively control PD-L1 positive tumors in vitro and in vivo with minimal toxicities. Cancer Research. 81(13_Supplement). LB148–LB148. 3 indexed citations
2.
3.
Porter, Sarah, et al.. (2020). Olive oil varieties cultivated in Morocco reduce reactive oxygen species and cell viability of human cervical cancer cells. Mediterranean Journal of Nutrition and Metabolism. 13(1). 89–100. 3 indexed citations
4.
Porter, Sarah, et al.. (2018). Using Biological Organisms as Chemical Sensors: The MicRoboCop Project. Journal of Chemical Education. 95(8). 1392–1397. 1 indexed citations
5.
Hawk, William A., et al.. (2017). Adoptive transfer of murine T cells expressing a chimeric‐PD1‐Dap10 receptor as an immunotherapy for lymphoma. Immunology. 152(3). 472–483. 23 indexed citations
6.
Barber, Amorette, et al.. (2014). NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8+ T cells. Molecular Immunology. 63(2). 268–278. 21 indexed citations
7.
8.
Spear, Paul W., Amorette Barber, & Charles L. Sentman. (2013). Collaboration of chimeric antigen receptor (CAR)-expressing T cells and host T cells for optimal elimination of established ovarian tumors. OncoImmunology. 2(4). e23564–e23564. 47 indexed citations
9.
Spear, Paul W., Amorette Barber, Agnieszka Rynda‐Apple, & Charles L. Sentman. (2013). NKG2D CAR T‐cell therapy inhibits the growth of NKG2D ligand heterogeneous tumors. Immunology and Cell Biology. 91(6). 435–440. 62 indexed citations
10.
Barber, Amorette, et al.. (2009). Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment. The Journal of Immunology. 183(11). 6939–6947. 85 indexed citations
11.
Barber, Amorette & Charles L. Sentman. (2009). Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity. The Journal of Immunology. 183(4). 2365–2372. 29 indexed citations
12.
Cubillos‐Ruiz, Juan R., Xavier Engle, Uciane K. Scarlett, et al.. (2009). Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity. Journal of Clinical Investigation. 119(8). 2231–44. 166 indexed citations
13.
Meehan, Kenneth R., et al.. (2008). Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy. Cytotherapy. 10(1). 30–37. 18 indexed citations
14.
Barber, Amorette, et al.. (2008). Chimeric NKG2D receptor–expressing T cells as an immunotherapy for multiple myeloma. Experimental Hematology. 36(10). 1318–1328. 63 indexed citations
15.
Barber, Amorette, Tong Zhang, & Charles L. Sentman. (2008). Immunotherapy with Chimeric NKG2D Receptors Leads to Long-Term Tumor-Free Survival and Development of Host Antitumor Immunity in Murine Ovarian Cancer. The Journal of Immunology. 180(1). 72–78. 69 indexed citations
16.
Barber, Amorette, Tong Zhang, Leslie R. DeMars, et al.. (2007). Chimeric NKG2D Receptor–Bearing T Cells as Immunotherapy for Ovarian Cancer. Cancer Research. 67(10). 5003–5008. 86 indexed citations
17.
Zhang, Tong, Amorette Barber, & Charles L. Sentman. (2007). Chimeric NKG2D–Modified T Cells Inhibit Systemic T-Cell Lymphoma Growth in a Manner Involving Multiple Cytokines and Cytotoxic Pathways. Cancer Research. 67(22). 11029–11036. 70 indexed citations
18.
Zhang, Tong, Amorette Barber, & Charles L. Sentman. (2006). Generation of Antitumor Responses by Genetic Modification of Primary Human T Cells with a Chimeric NKG2D Receptor. Cancer Research. 66(11). 5927–5933. 109 indexed citations
19.
Meadows, Sarah K., Mikael Eriksson, Amorette Barber, & Charles L. Sentman. (2006). Human NK cell IFN-γ production is regulated by endogenous TGF-β. International Immunopharmacology. 6(6). 1020–1028. 36 indexed citations
20.
Sentman, Charles L., et al.. (2006). NK Cell Receptors as Tools in Cancer Immunotherapy. Advances in cancer research. 95. 249–292. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew D. Fesnak Breakdown of academic impact, for papers by Connie P.M. Duong Breakdown of academic impact, for papers by Zachary A. Borman Breakdown of academic impact, for papers by Alba Rodríguez-García Breakdown of academic impact, for papers by Marc Wehrli Breakdown of academic impact, for papers by Clay Lyddane Breakdown of academic impact, for papers by Nicole Berndt Breakdown of academic impact, for papers by Angela C. Boroughs Breakdown of academic impact, for papers by Jessica Hartmann
Rankless by CCL
2026